Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-22

Clinical Trial Update: Low Dose Dexmedetomidine as a Postoperative Pain Adjunct [Phase 4]

View source ↗

Summary

Phase 4 clinical trial status update evaluating low-dose dexmedetomidine as a postoperative pain adjunct in adolescents with scoliosis undergoing spinal fusion;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Nichole Doyle | Conditions: Spinal Fusion, Adolescent Idiopathic Scoliosis | Phase 4 | Status: ENROLLING_BY_INVITATION